VIMTA LABS
Back to Income Statement
|
VIMTA LABS Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹318 Cr | ₹318 Cr | ₹278 Cr | ₹211 Cr | ₹181 Cr |
What is the latest Revenue of VIMTA LABS ?
Year | Revenue |
---|---|
Mar2024 | ₹318 Cr |
Mar2023 | ₹318 Cr |
Mar2022 | ₹278 Cr |
Mar2021 | ₹211 Cr |
Mar2020 | ₹181 Cr |
How is Revenue of VIMTA LABS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹318 Cr | 0.02 | |
Mar2023 | ₹318 Cr | 14.34 | |
Mar2022 | ₹278 Cr | 32.09 | |
Mar2021 | ₹211 Cr | 16.58 | |
Mar2020 | ₹181 Cr | - |
Compare Revenue of peers of VIMTA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VIMTA LABS | ₹2,006.7 Cr | -2.1% | -10.4% | 76.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,580.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,069.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,919.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,310.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,402.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
VIMTA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VIMTA LABS | -2.1% |
-10.4% |
76.6% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses